Raghda Barham

Ms. Raghda Barham

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in Genes
Verified
Journal Article
Open access
PDF file
BABilal Azab
Bilal Azab
ZDZain Dardas
Zain Dardas
DADunia Aburizeg
Dunia Aburizeg
MBMuawyah Dawoud Al Bdour
Muawyah Dawoud Al Bdour
MAMohammed Abu-Ameerh
Mohammed Abu-Ameerh
AAAbdalla Awidi
Abdalla Awidi
Whole Exome Sequencing (WES) is a powerful approach for detecting sequence variations in the human genome. The aim of this study was to investigate the genetic defects in Jordanian patients with inherited retinal dystrophies (IRDs) using WES. WES was performed on proband patients’ DNA samples from 55 Jordanian families. Sanger sequencing was used for validation and segregation analysis of the detected, potential disease-causing variants (DCVs). Thirty-five putatively causative variants (6 novel and 29 known) in 21 IRD-associated genes were identified in 71% of probands (39 of the 55 families). Three families showed phenotypes different from the typically reported clinical findings associated with the causative genes. To our knowledge, this is the largest genetic analysis of IRDs in the Jordanian population to date. Our study also confirms that WES is a powerful tool for the molecular diagnosis of IRDs in large patient cohorts.

Verified
Journal Article
Open access
PDF file
NANidaa Ababneh
Nidaa Ababneh
RARazan AlDiqs
Razan AlDiqs
MGMohammad Gharandouq
Mohammad Gharandouq
MIMohammad A. Ismail
Mohammad A. Ismail
RBRaghda Barham
Raghda Barham
Tareq SalehTareq Saleh
Tareq Saleh
Chemotherapy-induced neurotoxicity (CIN) is a major barrier against optimal anticancer treatment. This study investigated the neuroprotective effects of the naturally occurring antioxidant, Coenzyme Q10 (CoQ10), against CIN using a model of induced pluripotent stem cell (iPSC)-derived neurons. iPSCs have consistently proven to be reliable for disease modeling and drug discovery. We employed cell viability, oxidative stress, and mitochondrial function assays to measure the effect of 10 μM CoQ10 on iPSC-derived motor neuron progenitors (iPSC-MNPs) that were exposed to five chemotherapeutic agents: 5-Fluorouracil, methotrexate, paclitaxel (0, 1, and 10 μM) and doxorubicin, and vincristine (0, 0.1, and 1 μM). Our findings show that CoQ10 significantly reversed the reduction in cell viability inflicted by the exposure of iPSCs-MNPs to all five chemotherapeutics. Moreover, CoQ10 treatment resulted in a marked reduction in intracellular ROS levels and enhancement of mitochondrial membrane potential (MMP) in a drug- and dose-dependent manners, highlighting its role in preserving mitochondrial health. This study is the first to explore the protective effects of CoQ10 against CIN using an iPSC-derived neuronal platform, offering insights into its potential therapeutic use. Further investigation is essential to validate these findings and to determine the behavioral effects of CoQ10 in in vivo models of CIN.

Verified
Journal Article
Open access
PDF file
NANidaa Ababneh
Nidaa Ababneh
RARazan AlDiqs
Razan AlDiqs
SNSura Nashwan
Sura Nashwan
MIMohammad A. Ismail
Mohammad A. Ismail
RBRaghda Barham
Raghda Barham
Tareq SalehTareq Saleh
Tareq Saleh
Mesenchymal stem cell-derived exosomes (MSC-Exos) play a key role in tissue repair, immune regulation, and cancer biology. Due to limitations in MSC expansion and source variability, interest has shifted to induced pluripotent stem cell-derived MSCs (iMSCs) as a promising alternative. This study compares effects of exosomes derived from iMSCs (iMSC-Exos) and Wharton’s jelly MSCs (WJMSC-Exos) on MCF7 and A549 cancer cells. Both types of exosomes reduced MCF7 proliferation and induced a senescence-like state, rather than apoptosis, although the antiproliferative effect was transient in A549 cells. Notably, WJMSC-Exos promoted migration in both MCF7 and A549, whereas iMSC-Exos did not exhibit this effect. Overall, WJMSC-Exos had a more robust impact on cancer cell proliferation and migration. These findings highlight the diverse effects of exosomes on cancer and the development of a senescence-like state as an important response to Exos exposure. Moreover, these findings invite for more careful evaluation of the therapeutic role of iMSC-derived Exos.

26 October 2026 in Life
Verified
Journal Article
Open access
PDF file
MAMohammad Abufaraj
Mohammad Abufaraj
SASarah B. Al-Qalalweh
Sarah B. Al-Qalalweh
NSNabil William Sweis
Nabil William Sweis
FNFairouz Nairat
Fairouz Nairat
NSNabil William Sweis
Nabil William Sweis
NANidaa Ababneh
Nidaa Ababneh
Bladder cancer (BCa) diagnosis and surveillance rely heavily on invasive cystoscopy and urine cytology, which has limited sensitivity, underscoring the need for reliable non-invasive biomarkers. ENOX2 (tumor-associated NOX) is a candidate pan-cancer biomarker shed from tumor cell membranes into biological fluids, but its utility in BCa remains unexplored. This prospective pilot study enrolled 33 non-muscle-invasive bladder cancer (NMIBC) cases, 32 non-cancer controls for the primary analysis, and 38 other cancer controls. Serum and urinary ENOX2 were measured by ELISA, and ENOX2 gene expression by qPCR. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC). The urinary ENOX2/creatinine ratio was significantly higher in NMIBC cases than controls (median 17.95 vs 0.74 ng/mg, p = 0.018), achieving the highest diagnostic performance among studied markers (AUC 0.670, with sensitivity 53% and specificity 91% at a cutoff of ≥17.85 ng/mg), while serum ENOX2 and qPCR expression showed no diagnostic utility (AUC 0.435 and 0.417, respectively). Further exploratory analyses showed that the urinary ENOX2/creatinine ratio demonstrated comparable AUC across low- and high-grade tumors and correlated with tumor size. Additionally, the levels did not vary across benign urological conditions. The urinary ENOX2/creatinine ratio demonstrates modest but statistically significant diagnostic utility in NMIBC, outperforming serum ENOX2 measures in this pilot study. Further evaluation of ENOX2 in larger, multicenter cohorts, including its potential role within multimarker diagnostic panels, is recommended.

13 October 2026 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
Tareq SalehTareq Saleh
Tareq Saleh
MIMohammad A. Ismail
Mohammad A. Ismail
MSMirvat Surakhy
Mirvat Surakhy
FNFairouz Nairat
Fairouz Nairat
MGMohammad Gharandouq
Mohammad Gharandouq
NANidaa A. Ababneh
Nidaa A. Ababneh
Introduction/Objective: Hypoxia is a critical component of the tumor microenvironment contributing to metabolic reprogramming and drug resistance. Subsequently, elucidating the molecular mechanisms involved in hypoxia regulation in tumor cell models is essential. Methods: This study used CRISPR/Cas9 to knock out hepatocyte nuclear factor 4-alpha (HNF4-α) and hypoxia-inducible factor 1-alpha (HIF1-α) in HEPG2 cells. This study then assessed the effects of both knockouts (KO) on proliferation, migration, drug sensitivity, mitochondrial membrane stability, and gene expression in HEPG2 cells under both hypoxic and normoxic conditions. Results: Our data demonstrate that HIF1-α KO, but not HNF4-α KO, sensitizes HEPG2 cells to doxorubicin under hypoxic conditions. Additionally, the KO of both HIF1-α and HNF4-α enhances cell migration, irrespective of oxygen levels. Importantly, both HIF1-α and HNF4-α are required for cellular response to hypoxia and the maintenance of mitochondrial function, as evidenced by the loss of mitochondrial membrane potential increase under hypoxia in KO cells. Microarray-based transcriptomic profiling of HEPG2 cells revealed separation between HNF4-α and HIF1-α KO cells and controls under hypoxic versus normoxic conditions, with a markedly higher number of differentially expressed genes in hypoxia (up to 5,595 genes; adjusted p < 0.05, log2FC ±1.5). Both HNF4-α and HIF1-α contribute to hypoxia-responsive pathways, with impaired induction of key genes such as VEGFA and AK4 in KO cells, while GSEA indicated minimal effects of HNF4-α loss under hypoxia but pronounced metabolic pathway disruption in HIF1-α KO cells. Moreover, key regulators of mitochondrial function and mitophagy, including FUNDC1, MIEF1, and MIEF2, were upregulated in control hypoxic cells but not in KO cells. Discussion: These findings suggest that, in this single HEPG2 cell line model, HNF4-α contributes to the regulation of cell migration and mitochondrial stability under hypoxic conditions. Conclusion: Further investigation into the role of HNF4-α in tumor biology is encouraged.